| Literature DB >> 33492141 |
Wen-Yun Hsueh1, Ying-Shuan E Lee2, Min-Sian Huang1, Chin-Hung Lai3, Yu-Sheng Gao1, Jo-Chu Lin1, Yu-Fen Chen1, Chih-Lin Chang1, Shan-Yen Chou2, Shyh-Fong Chen2, Yann-Yu Lu2, Lien-Hsiang Chang2, Shu Fu Lin2, Yu-Hsiang Lin2, Pi-Chen Hsu2, Win-Yin Wei2, Ya-Chi Huang2, Yi-Feng Kao2, Li-Wei Teng2, Hung-Huang Liu2, Ying-Chou Chen2, Ta-Tung Yuan2, Ya-Wen Chan1, Po-Hsun Huang1, Yu-Ting Chao1, Shin-Yi Huang1, Bo-Han Jian1, Hsin-Yi Huang1, Sheng-Chuan Yang2, Tzu-Hao Lo1, Guan-Ru Huang1, Shao-Yun Wang1, Her-Sheng Lin2, Shih-Hsien Chuang2, Jiann-Jyh Huang1,2.
Abstract
In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33492141 DOI: 10.1021/acs.jmedchem.0c00727
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446